Ovarian cancer endpoints workshop
Executive Summary
FDA and the American Society for Clinical Oncology, in conjunction with FDA's Oncologic Drugs Advisory Committee, will hold a public workshop on ovarian cancer endpoints April 26 at the Marriott Hotel in North Bethesda, Md. FDA plans to issue a guidance document from the workshop findings. The agency has previously held meetings on lung, colorectal, prostate and brain cancer endpoints (1"The Pink Sheet" Feb. 6, 2006, p. 15). [Editor's note: To 2watch a webcastor order a video/DVD of this or any other meeting, visit FDAAdvisoryCommittee.com.]...
You may also be interested in...
Progression-Free Survival Is Meaningful Endpoint For Glioma Trials
Progression free survival assessed at six months should be considered as a meaningful surrogate endpoint in evaluating primary brain tumor clinical trials for accelerated approval, a panel assembled by FDA agreed
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.